Pages that link to "Q73206530"
Jump to navigation
Jump to search
The following pages link to Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I-II study (Q73206530):
Displaying 26 items.
- Toxicity and management in CAR T-cell therapy (Q28075314) (← links)
- Graft T-cell depletion as a prerequisite for the modulation of alloreactivity after haematopoietic stem cell transplantation (Q33579429) (← links)
- Would suicide gene therapy solve the 'T-cell dilemma' of allogeneic bone marrow transplantation? (Q33594118) (← links)
- Adoptive allogeneic immunotherapy--history and future perspectives (Q34062749) (← links)
- Suicide-gene-Transduced donor T-cells for controlled graft-versus-host disease and graft-versus-tumor (Q35015535) (← links)
- Contributions of gene marking to cell and gene therapies. (Q35059829) (← links)
- Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation (Q37793222) (← links)
- Current status of ex vivo gene therapy for hematological disorders: a review of clinical trials in Japan around the world (Q38862302) (← links)
- Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions (Q40314396) (← links)
- Herpes simplex thymidine kinase gene-transduced donor lymphocyte infusions (Q40556909) (← links)
- Transcellular transfer of active HSV-1 thymidine kinase mediated by an 11-amino-acid peptide from HIV-1 Tat. (Q44253862) (← links)
- Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes (Q44495832) (← links)
- Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy (Q45714279) (← links)
- Transient control of a virus-induced immunopathology by genetic immunosuppression. (Q45740302) (← links)
- Extensive vitiligo after ganciclovir treatment of GvHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinase (Q45744121) (← links)
- Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector (Q45867362) (← links)
- Functional and phenotypic variations in human T cells subjected to retroviral-mediated gene transfer (Q45871737) (← links)
- Exposure to hypomethylating agent, 5-azacytidine, may improve iCasp9 suicide gene therapy for treating GvHD in allografts. (Q45885332) (← links)
- In vivo alloreactive potential of ex vivo-expanded primary T lymphocytes (Q47980498) (← links)
- A Closed Culture System for the Ex Vivo Transduction and Expansion of Human T Lymphocytes (Q53951252) (← links)
- Ex vivo T lymphocyte expansion for retroviral transduction: influence of serum-free media on variations in cell expansion rates and lymphocyte subset distribution. (Q54033880) (← links)
- Retrovirus-Mediated Transfer of the Herpes Simplex Type I Thymidine Kinase Gene in Alloreactive T Lymphocytes (Q54147941) (← links)
- Alpha-Herpesvirus Thymidine Kinase Genes Mediate Viral Virulence and Are Potential Therapeutic Targets (Q64256864) (← links)
- [Contribution of antineoplastic biotherapy in the treatment of leukemia in children] (Q64378949) (← links)
- [Preparation of cell therapy products: contribution of closed systems] (Q73428221) (← links)
- Future prospects for CD8+ regulatory T cells in immune tolerance (Q90588415) (← links)